000			02058 a2200553 4500
005			20250515032424.0
264		0	_c20061220
008			200612s 0 0 eng d
022			_a0006-3223
024	7		_a10.1016/j.biopsych.2006.04.022 _2doi
040			_aNLM _beng _cNLM
100	1		_aBerridge, Craig W
245	0	0	_aMethylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. _h[electronic resource]
260			_bBiological psychiatry _cNov 2006
300			_a1111-20 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdrenergic Uptake Inhibitors _xblood
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aCatecholamines _xmetabolism
650	0	4	_aChromatography, High Pressure Liquid _xmethods
650	0	4	_aCognition _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Routes
650	0	4	_aElectroencephalography _xmethods
650	0	4	_aElectromyography _xmethods
650	0	4	_aMale
650	0	4	_aMemory, Short-Term _xdrug effects
650	0	4	_aMethylphenidate _xblood
650	0	4	_aMicrodialysis _xmethods
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aPrefrontal Cortex _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSignal Detection, Psychological _xdrug effects
650	0	4	_aSleep _xdrug effects
650	0	4	_aVision, Ocular _xdrug effects
700	1		_aDevilbiss, David M
700	1		_aAndrzejewski, Matthew E
700	1		_aArnsten, Amy F T
700	1		_aKelley, Ann E
700	1		_aSchmeichel, Brooke
700	1		_aHamilton, Christina
700	1		_aSpencer, Robert C
773	0		_tBiological psychiatry _gvol. 60 _gno. 10 _gp. 1111-20
856	4	0	_uhttps://doi.org/10.1016/j.biopsych.2006.04.022 _zAvailable from publisher's website
999			_c16399015 _d16399015